Vergoeding 2019-2023 voor ATC-subgroep L04A : Immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022* | 2023* | |
|---|---|---|---|---|---|
| L04AA Selectieve immunosuppressiva | 23.999.065 | 23.658.364 | 24.072.338 | 24.326.936 | 27.899.934 |
| L04AB Tumornecrosefactor-alfa-antagonisten | 279.621.442 | 206.226.008 | 188.294.590 | 158.512.919 | 150.459.465 |
| L04AC Interleukineremmers | 151.077.543 | 175.674.561 | 222.015.325 | 241.286.218 | 291.519.482 |
| L04AE Sfingosine-1-fosfaat (s1p) receptormodulatoren | . | . | . | 71.319 | 170.841 |
| L04AF Jak-remmers | 15.815.707 | 19.178.690 | 25.876.013 | 32.120.625 | 34.953.895 |
| L04AG Monoklonale antilichamen | 87.304.964 | 97.361.742 | 118.400.199 | 138.192.710 | 157.932.124 |
| L04AH Mtor-kinaseremmers | 67.384 | 37.200 | 58.759 | 70.484 | 54.571 |
| L04AJ Complement remmers | 37.946.931 | 35.584.078 | 34.429.032 | 36.541.639 | 38.283.248 |
| L04AX Overige immunosuppressiva | 150.508.892 | 163.895.217 | 162.880.157 | 54.213.298 | 29.520.005 |
| Totaal | 746.341.928 | 721.615.860 | 776.026.413 | 685.336.147 | 730.793.565 |